Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis

Cholangiopathies such as primary sclerosing cholangitis (PSC) cause damage to the bile ducts with no effective cure. Reduction and impairment in the function of regulatory T cells (Tregs) occur in PSC. We investigate whether Tregs regulate bile duct regeneration and the dynamics of Treg turnover during bile duct injury. We use the transgenic Foxp3<sup>GFPDTR</sup> model to mimic reduced Treg infiltration in PSC and show that Tregs mediate cholangiocyte response to biliary injury. Fate mapping of Tregs reveals that intrahepatic Tregs acquire a pro-inflammatory phenotype, even after interleukin-2 (IL-2)-mediated Treg expansion. Ox40L expression correlates with fibrosis in PSC patients. Enhancing Treg numbers through IL-2 complex administration and blocking Ox40 signaling simultaneously suppresses the inflammatory phenotype of Tregs and reduces bile duct damage and fibrosis. We demonstrate that bile duct regeneration can be enhanced by combining Treg-based therapy and targeting co-stimulatory molecules, such as Ox40L.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2025-11-01
DOI
https://doi.org/10.1016/j.celrep.2025.116557
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis

Prakash Ramachandran, Graham Anderson, Adriano G. Rossi, David R. Withers et al.
Cell Reports
Liver Diseases and Immunity
article

Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis

Prakash Ramachandran, Graham Anderson, Adriano G. Rossi, David R. Withers, Wei‐Yu Lu, Shuji Terai, Man Chun Wong, Naruhiro Kimura, Daniel A. Patten, M Müller, Atsunori Tsuchiya, Pei-Chi Huang, Shishir Shetty, Timothy James Kendall, Gareth Hardisty, Brian P. Higgins, Maxym Besh
article en

Abstract

Cholangiopathies such as primary sclerosing cholangitis (PSC) cause damage to the bile ducts with no effective cure. Reduction and impairment in the function of regulatory T cells (Tregs) occur in PSC. We investigate whether Tregs regulate bile duct regeneration and the dynamics of Treg turnover during bile duct injury. We use the transgenic Foxp3<sup>GFPDTR</sup> model to mimic reduced Treg infiltration in PSC and show that Tregs mediate cholangiocyte response to biliary injury. Fate mapping of Tregs reveals that intrahepatic Tregs acquire a pro-inflammatory phenotype, even after interleukin-2 (IL-2)-mediated Treg expansion. Ox40L expression correlates with fibrosis in PSC patients. Enhancing Treg numbers through IL-2 complex administration and blocking Ox40 signaling simultaneously suppresses the inflammatory phenotype of Tregs and reduces bile duct damage and fibrosis. We demonstrate that bile duct regeneration can be enhanced by combining Treg-based therapy and targeting co-stimulatory molecules, such as Ox40L.

Cell ReportsVol. 44(11)
NIHR Birmingham Liver Biomedical Research Unit (GB), University of Yamanashi Hospital (JP), Centre for Inflammation Research (GB), University of Yamanashi (JP), Niigata University (JP), University of Birmingham (GB)
Openalex Percentile: Top 55%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.